Nvidia, Boeing, Ardelyx, Crocs, Tesla: Why These 5 Stocks Are On Investors' Radars Today
These Biotech Stocks Could Double Your Money, According To Analysts
Nvidia, Boeing, Ardelyx, Crocs, Tesla: Why These 5 Stocks Are On Investors' Radars Today
These Biotech Stocks Could Double Your Money, According To Analysts
Elon Musk Questioned By Ethics Group Over Painful Deaths Of Monkeys Linked To Neuralink
EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug
Elon Musk Questioned By Ethics Group Over Painful Deaths Of Monkeys Linked To Neuralink
EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug
The Secret Behind Why Your Coffee and CBD Might Not Be Working
J&J Investors Will Soon Be Able To Exchange Shares For Kenvue Stocks
Biotech Recent News
5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies
The Companies That Led 2017's Biotech Rally
10 Biotech Stocks Moving From ASH 2017
It's A Bad Day For Biotechs
Pro: Biotech Is The Hottest ETF Of 2017 With Plenty Of Upside Ahead
A Sign Of Things To Come? Traders Are Betting On More Biotech Mergers
Small Biotechs Could Hurt From Scarcity Of Cancer Trial Participants
FDA's 60-Day Extension For Medical Device Defects Not Likely Obstructive To Public Health
Following Extended Consolidation Period, Biotech ETF's Next Breakout Could Be Big
Exclusive: CBMG CEO Talks Stem-Cell Therapies, Cancer Treatments, Financials & The Chinese Market
Viridian's President On Cannabis-Related Opportunities: AgTech And BioTech Offer Value To Investors
Biotech Stocks Convalescing After Wednesday's Trump-Inspired Biotech Selloff
Assessing The Legitimacy Of The Biotech ETF Bounce
4 Election-Proof Stocks: Biotech And Software Take The Lead
Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy
The Next Sector Rotation Will Be To Biotechs
Valeant Gets Closer To Left's $50 Target After New Accounting Fears
This Week Is Paramount For Biotech Stocks
12 Biotechs With Binary Events Coming This Year
Not All Of Clinton's Policies Are Bad For Pharmaceuticals
KaloBios, The Aftermath: Trader Starts GoFundMe To Pay Back $106,000 Balance
Eli Lilly Discontinues Evacetrapib; Investors Move Bets To Alternatives
Biotechs Coming Off One Of The Busiest Weeks In Recent Memory